Patent Assignment
Reel/Frame 044088/0497
Assignment of Assignor's Interest
Recorded: 2017-11-10
Pages: 2
Assignor
SANTARIS PHARMA A/S
Executed: 2007-03-22
Assignee
ENZON PHARMACEUTICALS, INC.
685 ROUTE 202/206, BRIDGEWATER, NEW JERSEY, 08807
Covered Property
(1)
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ENZON, INC.
Reel/Frame 044088/0512 →
Assignment of Assignor's Interest
Nov 10, 2017
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 044088/0538 →
Assignment of Assignor's Interest
Nov 10, 2017
From: WESTERGAARD, MAJKEN; THRUE, CHARLOTTE A.; RASMUSSEN, FRANK W.; HANSEN, HENRIK F.
To: SANTARIS PHARMA A/S
Reel/Frame 044088/0486 →
Change of Name
Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 044419/0290 →
Assignment of Assignor's Interest
Nov 10, 2017
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 044088/0517 →
Assignment of Assignor's Interest
Nov 10, 2017
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 044088/0520 →
Change of Name
Nov 28, 2017
From: SANTARIS PHARMA A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 044740/0854 →